Detection of Mucorales antigen in bronchoalveolar lavage samples using a newly developed lateral-flow device
Journal of Clinical Microbiology · 09.07.2025 · 63 (7)
DOI: 10.1128/jcm.00226-25 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 09.07.2025. Verfasst von Julie Rousselot und 9 weiteren Autor:innen. Beteiligte Einrichtung: Parasitology-Mycology Department, Besançon University Hospital, Besançon, France. Hauptthemen laut MEDLINE: Mucormycosis, Antigens, Fungal, Mucorales, Bronchoalveolar Lavage Fluid. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A murine IgG2b monoclonal antibody, named TG11, binding to an extracellular polysaccharide antigen secreted by all Mucorales fungi has been recently developed and integrated into a lateral-flow device (TG11-LFD). The aim of this study was to establish the clinical performance of TG11-LFD on bronchoalveolar lavage (BAL) fluids for the diagnosis of mucormycosis. Thirteen BAL samples from 13 patients with mucormycosis, all of which tested positive for Mucorales qPCR ( Mucor/Rhizopus [ n = 5], Lichtheimia [ n = 2], Rhizomucor [ n = 5], and Cunninghamella [ n = 1]), were used to assess the TG11-LFD. We also selected 49 BAL samples from 25 patients with other invasive fungal infections (IFI) (aspergillosis, Pneumocystis infection, candidiasis, and possible IFI) and from 20 patients without IFI for use as negative controls. The intensities of the test and control lines were recorded using a Cube reader. The diagnostic performance was assessed by analyzing the receiver operating characteristics (ROC) curve with the Jamovi software package (version 2.6.13). The area under the curve of the ROC curve was 0.739. Using a threshold value positivity ≤531 artificial units, the TG11-LFD test has a sensitivity and specificity of 76.92% and 75.51%, respectively, a positive predictive value of 45.45%, and a negative predictive value of 92.5%. In this study, we evaluated the performance of TG11-LFD on clinical samples for the first time and demonstrated its significant potential for enhancing the rapid detection of mucormycosis. Combining antigen detection with qPCR, as successfully applied in the diagnosis of aspergillosis, is likely to yield the most reliable diagnostic approach. IMPORTANCE Mucormycosis is a severe emerging, invasive fungal disease caused by fungi in the order Mucorales . The mortality rate remains high at approximately 50%. Rapid diagnosis and prompt initiation of targeted treatment are associated with an improved prognosis. Gold standard diagnostic procedures have poor sensitivity and long turnaround times. Mucorales polymerase chain reaction in blood and respiratory samples has improved diagnosis, but this technique is not widely available due to high costs and the need for specialist equipment. A prototype lateral-flow device (TG11-LFD) incorporating a mouse monoclonal antibody, which binds to an extracellular polysaccharide antigen specific to Mucorales fungi, has been recently developed. In this study, we evaluated for the first time the performance of the TG11-LFD test on clinical bronchoalveolar lavage fluids for diagnosing mucormycosis. With 76.92% sensitivity and 75.51% specificity, this innovative, simple, and affordable approach shows great potential for improving the rapid diagnosis of mucormycosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Parasitology-Mycology Department, Besançon University Hospital, Besançon, France.
- CNRS, Chrono-environnement (UMR 6249), Université Marie et Louis Pasteur, Besançon, France.
- MiVEGEC, Parasitology-Mycology, CNRS, IRD, Montpellier University Hospital, University of Montpellier, Montpellier, France.
- Parasitology-Mycology Department, Bordeaux University Hospital, Bordeaux, France.
- Institute of Infectious Agents, Parasitology and Medical Mycology Department, Hospices Civils de Lyon, Croix-Rousse Hospital, Lyon, France.
- Parasitology-Mycology Unit, Microbiology Department, Nancy Regional University Hospital-Hôpitaux de Brabois, Vandœuvre-Lès-Nancy, France.
ORCID-Profile: Laurence Millon, Damien Dupont, Christopher R Thornton
Zitieren
APA
Rousselot, J., Millon, L., Scherer, E., Bourgeois, N., Imbert, S., Dupont, D., Debourgogne, A., Maubon, D., Bellanger, A. P., & Thornton, C. R. (2025). Detection of Mucorales antigen in bronchoalveolar lavage samples using a newly developed lateral-flow device. Journal of Clinical Microbiology, 63(7). https://doi.org/10.1128/jcm.00226-25
Vancouver
Rousselot J, Millon L, Scherer E, Bourgeois N, Imbert S, Dupont D, et al. Detection of Mucorales antigen in bronchoalveolar lavage samples using a newly developed lateral-flow device. Journal of Clinical Microbiology. 2025;63(7). doi:10.1128/jcm.00226-25
BibTeX
@article{Rousselot2025,
author = {Rousselot, Julie and Millon, Laurence and Scherer, Emeline and Bourgeois, Nathalie and Imbert, Sebastien and Dupont, Damien and Debourgogne, Anne and Maubon, Danièle and Bellanger, Anne Pauline and Thornton, Christopher R},
title = {Detection of Mucorales antigen in bronchoalveolar lavage samples using a newly developed lateral-flow device},
journal = {Journal of Clinical Microbiology},
year = {2025},
volume = {63},
number = {7},
doi = {10.1128/jcm.00226-25}
}
EUVIMED